CLVS insider trading

Clovis Oncology, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
750
Last 90 days
0
Buys / sells
2% / 42%
Market cap

CLVS insider activity at a glance

FilingIQ has scored 750 insider transactions for CLVS since Jan 13, 2015. The most recent filing in our index is dated Nov 2, 2022.

Across the full history, 14 open-market purchases and 317 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CLVS insider trades is 55.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Frequently asked

How many insider trades does FilingIQ track for CLVS?
FilingIQ tracks 750 Form 4 insider transactions for CLVS (Clovis Oncology, Inc.), covering filings from Jan 13, 2015 onwards. 0 of those were filed in the last 90 days.
Are CLVS insiders net buyers or net sellers?
Across the full Form 4 history for CLVS, 14 transactions (2%) were open-market purchases and 317 (42%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CLVS insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

Methodology & sources

Every CLVS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.